A Study of LY2875358 in Participants With Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

August 28, 2013

Primary Completion Date

March 14, 2016

Study Completion Date

December 31, 2025

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
BIOLOGICAL

LY2875358

Administered IV

DRUG

Erlotinib

Administered Orally

Trial Locations (45)

2100

Rigshospitalet, Copenhagen

2730

Herlev and Gentofte Hospital, Herlev

5000

Odense Universitetshospital, Odense C

10002

National Taiwan University Hospital, Taipei

10043

Azienda Sanitaria Ospedaliera S Luigi Gonzaga, Orbassano

11217

Taipei Veterans General Hospital, Taipei

13620

Seoul National University Bundang Hospital, Seongnam

14033

CHU de Caen Hopital Cote de Nacre, Caen

14165

Helios Klinikum Emil von Behring Berlin-Zehlendorf, Berlin

21565

Gachon University Gil Medical Center, Namdong-gu

23538

Universitätsklinikum Schleswig-Holstein, Lübeck

26100

Istituti Ospedalieri di Cremona, Cremona

28222

Hospital Puerta De Hierro, Majadahonda

28223

Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón

28644

Chungbuk National University Hospital, Cheongju-si

31008

Clinica Universitaria De Navarra, Pamplona

34295

Hôpital Arnaud de Villeneuve - CHU Montpellier, Montpellier

35128

Istituto Oncologico Veneto IRCCS, Padua

38043

CHU De Grenoble Hopital Albert Michallon, Grenoble

40447

China Medical University Hospital, Taichung

40705

Taichung Veterans General Hospital, Taichung

44033

Ulsan University Hospital, Ulsan

50134

Azienda Ospedaliera Universitaria Careggi, Florence

51109

Klinikum Köln-Merheim, Cologne

63000

Chu Gabriel Montpied, Clermont-Ferrand

69126

Thoraxklinik-Heidelberg gGmbH, Heidelberg

69677

HCL-Hôpital Louis Pradel, Lyon (Bron) Cedex

70124

"Istituto Tumori Giovanni Paolo II", Bari

70839

Klinik Schillerhöhe, Gerlingen

86021

CHU la Miletrie, Poitiers

89075

Universitätsklinikum Ulm, Ulm

5223 GZ

Jeroen Bosch Hospital, 's-Hertogenbosch

6815 AD

Ziekenhuis Rijnstate, Arnhem

3844 DG

Ziekenhuis St. Jansdal, Harderwijk

3435 CM

St. Antonius Ziekenhuis, locatie Nieuwegein, Nieuwegein

03722

Severance Hospital, Yonsei University Health System, Seoul

05505

Asan Medical Center, Seoul

06351

Samsung Medical Center, Seoul

08208

Corporacion Sanitaria Parc Tauli, Sabadell

08003

Hospital del Mar, Barcelona

G12OYN

Gartnavel General Hospital, Glasgow

W6 8RF

Charing Cross Hospital, Chelsea

M23 9LT

Wythenshawe Hospital, Wythenshawe

WV10 0QP

New Cross Hospital, Wolverhampton

OX3 7LJ

Churchill Hospital, Oxford

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY